Natco Pharma, others sued in US for generic cancer drug

The company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (ANDA) holder and distribution partner for the generic product in the US, it added. Natco Pharma shares were trading 3.13 per cent down at Rs 885.00 apiece on the BSE.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news